我要投票 宝矿力水特在运动饮料行业中的票数:10
· 外 推 电 报 ·
2024-11-21 20:33:52 星期四

【宝矿力水特是哪个国家的品牌?】

宝矿力水特是什么牌子?「宝矿力水特」是大冢(中国)投资有限公司旗下著名品牌。该品牌发源于上海,由创始人张一在2003期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

生命源于海洋,大海孕育万物。在远古的海床中,蕴藏着人体所需的钠、钾、钙等电解质。

宝矿力水特是世界著名点滴注射液生产商—日本大冢制药株式会社根据“喝的点滴”的理念,利用人体工程学及运动生理学等科学原理,就人的行为、生活和运动等方面进行研究而开发的具有世界级品质的电解质补充饮料。实现了“静脉注射水分补给”到“口服水分补给”的转变。

宝矿力水特其吸收速度比水快,体内贮留时间比水厂,适合多种情况下的补水需求,并且低热量、不含色素和防腐剂,可安心饮用。

宝矿力水特自问世以来,风靡世界17个国家和地区,深受广大消费者的信赖与喜爱。

大冢制药1921年在日本创立,至今已有87年的历史。大冢制药以“Otsuka-Peoplecreatingnewproductsforbetterhealthworldwide”为企业理念,以为全世界人民的健康做出贡献为目标,开展经营活动。大冢制药1946年开始发展输液事业,1964年成立了现在的大冢制药株式会社。大冢制药经营范围遍布全世界,包括:中国,美国,欧洲,韩国,印尼,中国香港,中东等。

大冢制药以‘Otsuka-peoplecreatingnewproductsforbetterhealthworldwide’为企业理念,以为人类健康做贡献为目标,开展着经营活动。其核心业务包括『治疗疾病的医药品事业』与『支援人们每日健康的消费者商品事业』,研发、生产并销售有助于人类健康的极富创新意义的产品。大冢制药作为一家健康关联企业,将始终保持高度的伦理观,培育充满活力的企业文化,谋求与当地社会共存,与自然环境协调,从而成为“全球性的价值创造企业”。2007年度的合计销售额约为9,284亿日元。

大冢制药及其子公司,相关公司构成的大冢制药集团,在世界18个国家和地区拥有106家公司与约33,000名员工。

英文翻译:Life comes from the sea, which breeds everything. In the ancient sea bed, there are electrolytes such as sodium, potassium and calcium needed by human body. Baumine Lishui is a world-famous drop injection manufacturer, Otsuka Pharmaceutical Co., Ltd. in Japan. Based on the concept of "drop by drop" and the scientific principles of ergonomics and sports physiology, baumine Lishui researched and developed the world-class quality electrolyte supplement drink on the aspects of human behavior, life and sports. The change from "intravenous water supply" to "oral water supply" has been realized. Baokuangli water, especially its absorption speed is faster than that of water, and its internal storage time is longer than that of water plant. It is suitable for water replenishment in various situations, and it has low heat, no pigment and preservative, and can be safely drunk. Since its appearance, baokuangshui has been popular in 17 countries and regions around the world, deeply trusted and loved by consumers. Otsuka pharmaceutical was founded in Japan in 1921 and has a history of 87 years. Otsuka pharmaceutical takes "Otsuka people creating new products for better health worldwide" as its business philosophy, aims to make contributions to the health of people all over the world, and carries out business activities. Otsuka pharmaceutical started to develop infusion business in 1946, and established the current Otsuka Pharmaceutical Co., Ltd. in 1964. Otsuka's business scope covers the world, including China, the United States, Europe, South Korea, Indonesia, Hong Kong, the Middle East, etc. Otsuka pharmaceutical takes "Otsuka people creating new products for better health worldwide" as its business philosophy, aims to contribute to human health, and carries out business activities. Its core business includes "medical products for treating diseases" and "consumer goods for supporting people's daily health". It develops, produces and sells innovative products that contribute to human health. As a health related enterprise, Otsuka pharmaceutical will always maintain a high level of ethics, cultivate a vibrant corporate culture, seek to coexist with the local society and coordinate with the natural environment, so as to become a "global value creation enterprise". The total sales in 2007 was about 928.4 billion yen. Otsuka pharmaceutical and its subsidiaries, the Otsuka pharmaceutical group composed of related companies, have 106 companies and about 33000 employees in 18 countries and regions in the world.

本文链接: https://www.waitui.com/brand/1f74b5957.html 联系电话:021-53966838

千城特选小程序码

7×24h 快讯

拼多多:第三季度营收增速环比下降,将坚定高质量发展战略应对竞争挑战

36氪获悉,拼多多发布2024年第三季度财报。财报显示,本季度拼多多营收达到994亿元,与上个季度相比,营收的增速有所放缓。业内分析认为,一方面是因为电商行业的竞争依然激烈,另一方面是平台的“百亿减免”等举措影响了短期的财报表现。“为了应对行业竞争,我们将坚定地执行高质量发展战略,继续实行‘减免+扶持’的举措,持续完善平台及产业生态,为供需两侧带来更大的普惠。”拼多多陈磊表示。

34分钟前

拼多多:第三季度利润环比下降22%,将长期投入“新质供给”“电商西进”战略

36氪获悉,拼多多发布2024年第三季度财报。财报显示,本季度拼多多利润达到250亿元,环比下降22%。过去这个季度,拼多多先后推出“百亿减免”“电商西进”“新质商家扶持计划”等重磅举措,持续扩大对生态建设的投资,一定程度上影响了短期的财报表现。拼多多陈磊表示,在财务数据之外,我们更加看重生态投资带来的长期价值,未来几个季度,拼多多将继续投入“新质供给”“电商西进”等战略,给用户、商家及产业带来更长远的回报。

34分钟前

莎普爱思:股东拟合计减持不超5%公司股份

36氪获悉,莎普爱思公告,股东陈德康持有公司12.39%股份,上海景兴实业投资有限公司持有公司4.7%股份。陈德康计划减持公司股份数量合计不超过758.32万股,即不超过公司总股本的2%。上海景兴计划减持公司股份数量合计不超过1137.48万股,即不超过公司总股本的3%。

34分钟前

永杰新材上交所主板IPO申请获证监会同意注册批复

36氪获悉,证监会下发关于同意永杰新材料股份有限公司首次公开发行股票注册的批复,同意该公司首次公开发行股票的注册申请。根据招股书,该公司拟在上交所主板上市,公司专业从事铝板带箔的研发、生产与销售,产品主要包括铝板带和铝箔两大类。

34分钟前

东方电缆:公司及子公司近期中标合计约40亿元海底电缆项目

36氪获悉,东方电缆公告,公司及全资子公司东方海工院近期收到相关通知书,确认公司及东方海工院联合体为相关项目中标人。其中,直流海底电缆项目中标金额约15.14亿元,交流海底电缆项目中标金额合计约24.72亿元,以上项目合计中标金额约40亿元。同日公告,公司拟以自有资金投资建设东方中央研究院·总部项目,项目总投资金额约为5.54亿元。

34分钟前

本页详细列出关于康之味的品牌信息,含品牌所属公司介绍,康之味所处行业的品牌地位及优势。
咨询